This rate applies to adults aged 18-64 in Connecticut, based on data from 2021-2023.
Key Takeaways
- Approximately 1.2% of adults in Connecticut are affected by schizophrenia, a rate slightly higher than some national estimates.1.2%[5]
- A significant treatment gap exists, with an estimated 35% of individuals with schizophrenia in the state not receiving adequate care.35%[4]
- Racial disparities are evident, as the prevalence among African American adults (1.8%) is significantly higher than among non-Hispanic White adults (1.0%).1.8%[1]
- Connecticut faces a shortage of specialized providers, with 28 per 100,000 population, falling below the national average of 35.28 per 100k[2]
- Hospitalization rates for schizophrenia in Connecticut, at 22 per 100,000 people, exceed the national incidence of 18 per 100,000.22 per 100k[7]
- Nationally, the economic burden of schizophrenia is immense, with annual excess costs reaching up to $343 billion.$343 billion[8]
Schizophrenia
Source: State and County Dashboard | Mental Health America. Mhanational. Published 2020.
Schizophrenia Prevalence in Connecticut
Understanding the prevalence of schizophrenia is the first step in assessing the condition's impact on a community. In Connecticut, about one in five adults experiences any mental illness[10], with 5.0% having a serious mental illness (SMI)[10]. Schizophrenia represents a significant portion of SMI cases. It's important to note that prevalence estimates can vary due to differences in diagnostic criteria and the underrepresentation of populations like those in institutions or without stable housing[6]. For instance, while many state-level surveys in Connecticut report a 12-month prevalence of around 1.2%[4], other rigorous surveys have found a rate of 0.9%[1].
The estimated lifetime prevalence rate of schizophrenia among adults in Connecticut.
The typical prevalence range reported in U.S. household surveys and clinical interviews.
A higher estimate that includes harder-to-reach populations in shelters and correctional facilities.
The rate of adults in Connecticut who screen at risk for developing psychosis.
Demographic and Geographic Disparities
Schizophrenia does not affect all populations equally. Significant disparities exist across gender, race, and geography, often influenced by social determinants of health such as income inequality and urban density[13]. These factors can exacerbate mental health disorders and create barriers to care. For example, data shows that racial and ethnic minority groups in Connecticut, particularly Black and Hispanic individuals, are often underrepresented in treatment statistics relative to their population size[9]. The following data highlights some of the key demographic differences observed within the state.
Treatment Rates and Gaps in Care
Receiving timely and effective treatment is crucial for managing schizophrenia, yet many individuals face significant barriers. Under-treated schizophrenia is associated with a poor quality of life, higher rates of hospitalization, and a substantial economic impact on families and communities[12]. The data reveals a concerning gap between the number of people diagnosed and those receiving consistent, evidence-based care in Connecticut. This gap highlights the ongoing need for improved outreach, reduced stigma, and better-funded services.
Percentage of adults with schizophrenia in Connecticut receiving regular, evidence-based treatment.
Of those with a clinical diagnosis, the percentage who reported receiving ongoing psychiatric or psychosocial treatment.
Percentage of diagnosed individuals who received antipsychotic medication in the past year.
An estimate suggesting nearly 60% of individuals with schizophrenia in Connecticut may be underserved.
Access to Care: Providers and Policies
Access to mental healthcare in Connecticut is a complex issue with both strengths and weaknesses. While the state has a high rate of insurance coverage, with approximately 90% of residents covered for mental health services[11], challenges remain. Persistent stigma, limited funding for specialized services, and regional infrastructure disparities contribute to low treatment rates[12]. Furthermore, many counties have a Health Professional Shortage Area (HPSA) designation for mental health, limiting rapid access to care[10]. Even with a high state average of psychiatrists, their uneven distribution means rural parts of Connecticut remain underserved[6].
The Role of Medicaid and State Policies
Public programs like Medicaid play a vital role in providing care for individuals with schizophrenia. In Connecticut, legislative changes aimed at increasing Medicaid coverage and reimbursements have led to higher treatment participation[2]. These proactive policies have helped position Connecticut among the top 10 states for mental health support[11]. The data below illustrates key metrics for Medicaid recipients with schizophrenia in the state, showing both progress and areas for continued focus.
Economic Impact of Schizophrenia
The economic impact of schizophrenia is profound, encompassing direct healthcare costs, non-healthcare costs, and indirect costs from lost productivity and caregiving. Nationally, these costs are staggering, and states like Connecticut feel the impact through public health expenditures and support services. Connecticut allocates substantial funds for mental health relative to other states[14], including a recent 15% increase in funding for community mental health services between 2020 and 2023[3]. Understanding the cost breakdown is essential for effective policy and resource allocation.
Lost productivity, caregiving, and premature mortality make up the majority of schizophrenia's economic burden nationally.
TacCaregiving for individuals with schizophrenia accounts for nearly one-third of all indirect costs.
TacDriven by rising inpatient and outpatient service use, direct healthcare costs have risen significantly.
TacState Trends and Outcomes
Tracking trends over time provides insight into the evolving landscape of schizophrenia care and prevalence in Connecticut. The state's mental health services have gradually shifted from primarily inpatient care to more community-based models[17]. However, recent data indicates a slight increase in prevalence and positive screenings for psychotic disorders, highlighting the need for continued vigilance and investment in mental health infrastructure. Examining outcomes like suicide rates provides a sobering reminder of the serious consequences of severe mental illness.
The approximate increase in the prevalence rate of schizophrenia in Connecticut from 2018 to 2023.
The increase in individuals screening positive for severe mental health concerns related to psychotic disorders.
The approximate annual increasing trend in reported cases of schizophrenia over the past five years.
Suicide Rates: Connecticut vs. National Average
Frequently Asked Questions
Sources & References
All statistics and claims on this page are supported by peer-reviewed research and official government data sources.
